Skip to main content
. 2020 May 26;12(6):1363. doi: 10.3390/cancers12061363
BC breast cancer
CCK-8 cell counting kit-8
CTRL control
DAB 3,3′-diaminobenzidine tetrahydrochloride
DAPI 4′,6-diamidino-2-phenyindole, dilactate
DMEM Dulbecco’s modification of Eagle medium
EC endothelial cell
ECL enhanced chemiluminescence
ER estrogen receptors
ERK extracellular-signal-regulated kinase
ESM-1 endothelial cell-specific molecule 1
EV empty vector
FBS fetal bovine serum
HER2 human epidermal growth factor receptor 2
HIF-1α hypoxia-inducible factor 1 alpha
ICAM-1 intercellular adhesion molecule-1
IFNγ interferon gamma
IHC immunohistochemistry
IL-1β interleukin 1 beta
MDA-MB-231 BR MDA-MB-231 cells with a brain metastatic phenotype
MMP matrix metalloproteinase
NF-κB nuclear factor kappa B
PDK1 phosphoinoisitide dependent kinase 1
PI3K phosphoinositide 3-kinase
PKC protein kinase C
PR progesterone receptors
P2Y2R P2Y purinergic receptor 2
RT-PCR reverse transcription-polymerase chain reaction
RT radiotherapy
RT-R radiotherapy resistant
SD standard deviation
SDS-PAGE sodium dodecyl sulfate-polyacrylamide gel electrophoresis
siRNA small interfering RNA
STAT-3 signal transducer and activator of transcription 3
TNBC triple negative breast cancer
TNFα tumor necrosis factor alpha
VCAM-1 vascular cell adhesion molecule-1
VEGF vascular endothelial growth factor